Presenters

Karen Del'Olio | Author, Co-Author

karen.del'olio@umassmed.edu;
Karen Del’Olio, MPH is Research Program Manager for the CMV TransmIT Study at UMass Chan Medical School where she assists to lead study development and implementation and serve as a liaison between the study team and its partners. Karen is a mixed methods researcher with experience in academia and the biotech/pharmaceutical industry encompassing such areas as community based participatory research, community engagement and partnership building, participant and community partner recruitment and retention and working collaboratively with Community Advisory Boards, key informant experts and community partners. She received her Master's degree in Public Health from the University of Massachusetts.

---

John Diaz-Decaro | Author, Co-Author

John.Diaz-Decaro@modernatx.com;
Dr. Diaz-Decaro is Director and Lead Epidemiologist for Moderna’s mRNA-1647 CMV vaccine candidate. John supports all epidemiology-related activities for the CMV development program, including addressing evidence gaps in the field, highlighting the direct and indirect benefits of CMV vaccination, and supporting federal and state discussions on the importance of newborn screening. He received his PhD from the UCLA Fielding School of Public Health.

---

Timothy Kowalik | Co-Author

timothy.kowalik@umassmed.edu;
Timothy Kowalik, Ph.D. has been studying CMV since 1990. Prior to CMV research, he studied the genetics of bluetongue virus, a pathogen of ruminants including cattle, during his graduate training at Utah State University. Upon obtaining his PhD, he moved to North Carolina for postdoctoral studies at the University of North Carolina School of Medicine and then at Duke University Medical School. In 1996, he joined the faculty at the University of Massachusetts Medical, where is currently an Associate Professor of Microbiology and Physiological Systems.

---

Elizabeth Orvek | Co-Author

elizabeth.orvek@umassmed.edu;
N/A

---

Lauren Howe | POC-Point of Contact

lauren.howe@umassmed.edu;
N/A

---

Kelsey Woods | Co-Author

kelsey.woods1@umassmed.edu;
N/A

---

Syed Naeem | Author, Co-Author

syed.naeem@umassmed.edu;
N/A

---

Cynthia Callaghan | Co-Author

cindi.callaghan@umassmed.edu;
N/A

---

Annie Geiger | Co-Presenter, Author, Co-Author

annie.geiger1@umassmed.edu;
Annie is a third-year medical student at UMass Chan Medical School. She received her master's degree in Pathology from the University of Cambridge and her Bachelor of Science in Biological Sciences from Cornell University.

---

Susan Druker | Co-Author

susan.druker@gmail.com;
N/A

---

Bruce Barton | Co-Author

bruce.barton@umassmed.edu;
N/A

---

Thejas Suvarna | Co-Author

suvarnaT@careevolution.com;
N/A

---

Emma Harman | Co-Author

emma.harman@careevolution.com;
N/A

---

Kelley Bridges | Co-Author

kelley.bridges@careevolution.com;
N/A

---

Summer Schrader | Co-Author

summer.schrader@careevolution.com;
N/A

---

Madeleine Hayden | Co-Author

madeleine.hayden@modernatx.com;
N/A

---

Sandeep Basnet | Co-Author

sandeep.basnet@modernatx.com;
N/A

---

Lori Panther | Co-Author

lori.panther@modernatx.com;
Lori Panther, MD, MPH is Senior Director of Clinical Development at Moderna, Inc., based in Cambridge, MA, USA. Dr. Panther is the Clinical Lead for Moderna’s investigational cytomegalovirus (CMV) vaccine program. Prior to joining Moderna in 2016, Dr. Panther was Assistant Professor of Medicine at Harvard Medical School and Associate Director for Clinical Research of the Fenway Institute at Beth Israel Deaconess Medical Center in Boston, MA, where she directed NIH- and industry-sponsored early- and late-phase vaccine trials and interventional trials of modalities to prevent sexually transmitted infections. Dr. Panther completed her Internal Medicine residency and chief residency at University of California, San Francisco, CA, USA; her Infectious Diseases fellowship at University of Washington, Seattle, WA, USA; and her Master of Public Health degree at the Harvard School of Public Health, Boston, MA, USA. Her research was focused on mucosal immunology of the genital tract in mother-to-child HIV transmission.

---

Laura Gibson | Primary Presenter

laura.gibson@umassmed.edu;
The current Med/Peds division chief, Laura returned to UMass Memorial Medical Center for a fellowship in Infectious Diseases after completing her Med/Peds residency at Baystate Medical Center. She is a graduate of Yale University and the University of Massachusetts Medical School. She remained at UMass after finishing her fellowship in 2001 to pursue research on cellular immune responses to human cytomegalovirus and other herpesviruses. She also serves on the general and transplant Infectious Diseases services in both the Departments of Medicine and Pediatrics.